Filter
1500
Text search:
drug
market
Featured
128
450
Language
Document type
809
285
188
86
77
23
17
7
5
1
1
1
Countries / Regions
80
64
59
50
48
40
37
35
32
30
29
28
26
26
25
20
20
20
19
16
16
14
14
13
13
12
10
10
10
9
9
8
8
8
8
8
7
6
6
6
6
6
6
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
640
90
70
52
40
39
13
Toolboxes
135
130
104
103
95
69
41
30
28
26
24
23
22
22
18
18
16
12
9
7
6
4
3
3
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Bull World Health Organ 2017;95:594–598
Towards the Peoples Health Assembly Book -1
Accessed November, 2017
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Therapeutics Information and Pharmacovigilance Centre | TIPC
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie
...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Progress in diagnosis: Akey in overcoming the MDR-TB crisis.
The expanse-TV project progress and impact brief.
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
